Cypress Capital Advisors, LLC Merck & Co., Inc. Transaction History
Cypress Capital Advisors, LLC
- $176 Billion
- Q3 2025
A detailed history of Cypress Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cypress Capital Advisors, LLC holds 9,170 shares of MRK stock, worth $851,526. This represents 0.44% of its overall portfolio holdings.
Number of Shares
9,170
Previous 9,599
4.47%
Holding current value
$851,526
Previous $760 Million
1.29%
% of portfolio
0.44%
Previous 0.48%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,881Shares Held
1.9BCall Options Held
30.1MPut Options Held
27.7M-
Vanguard Group Inc Valley Forge, PA252MShares$23.4 Billion0.33% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$11 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA75.3MShares$6.99 Billion1.16% of portfolio
-
Geode Capital Management, LLC Boston, MA59.8MShares$5.55 Billion0.33% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $235B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...